In the News


Large analysis finds no link between pioglitazone and bladder cancer in type 2 diabetes patients

Pioglitazone wasn't associated with higher incidence of bladder cancer in people with type 2 diabetes, according to a recent, multi-country analysis.

Care gaps identified in U.S. diabetic adults

Among U.S. adults with diabetes, 3 in 10 are undiagnosed, possibly due to limited access to care, a study recently reported.

Routine coronary angiography didn't reduce cardiac events in asymptomatic diabetics

Screening all diabetic patients for coronary artery disease using coronary computed tomography angiography did not reduce the rate of mortality or cardiovascular events, a study found.

MKSAP Quiz: Medication for a patient attempting conception

This month's quiz asks readers to evaluate a 32-year-old woman who is planning to attempt conception with her partner and has a history of systemic lupus erythematosus complicated by chronic kidney disease.

Diabetes associated with cognitive decline, CABG better than PCI for diabetics

Higher HbA1c at midlife was associated with greater cognitive decline over the following 20 years, and coronary artery bypass grafting is preferable to percutaneous coronary intervention in diabetics, according to studies recently published in Annals of Internal Medicine.

In metformin-treated type 2 diabetes mellitus, weekly dulaglutide was noninferior to daily liraglutide for HbA1c levels

Patients whose diabetes was inadequately controlled on metformin showed similar weight loss, improvement in HbA1c, and adverse events whether they took dulaglutide or liraglutide, a trial found.

Aspirin primary prevention trial in Japan halted for lack of mortality benefit

Low-dose aspirin for primary prevention reduced nonfatal myocardial infarction, but not death from cardiovascular causes, in older Japanese patients, a recent study found.

Spotlight on type 1 diabetes

A couple of significant studies in type 1 diabetes came out last month.

Physician editor: David V. O'Dell, MD, FACP